Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001498428-26-000002

CEO & President sold 2,683 shares at $18.33 ($49,179)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Cox John · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-16 Sale : show line 1 in the form 10b5-1 −2,683 $18.33 $49,179 368,151 D
Open-market sales · 2,683 sh · avg $18.33 · $49,179
Loading xslF345X06/ownership.xml…